Search Page

1

Cite

Share

Cognitive Dysfunction: Feasibility of a Brief Intervention to Help Breast Cancer Survivors.

Radomski M, Kreiger R, Anheluk M, Berling K, Darger M, Garcia H, Grabe K, Hopkins S, Morrison M, Zola J, Swenson KK. Radomski M, et al. Among authors: swenson kk. Clin J Oncol Nurs. 2021 Dec 1;25(6):E69-E76. doi: 10.1188/21.CJON.E69-E76. Clin J Oncol Nurs. 2021. PMID: 34800105

Cite

Share

2

Cite

Share

HER2 Testing: Insights From Pathologists' Perspective on Technically Challenging HER2 FISH Cases.

Grimm EV, Allison KH, Hicks DG, Swenson KK, Krueger J, Yaziji H, Downs-Kelly E, Rendi MH, Susnik B, Tsai ML, Lillemoe TJ. Grimm EV, et al. Among authors: swenson kk. Appl Immunohistochem Mol Morphol. 2021 Oct 1;29(9):635-642. doi: 10.1097/PAI.0000000000000946. Appl Immunohistochem Mol Morphol. 2021. PMID: 34282066

Cite

Share

3

Cite

Share

Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.

Tsai ML, Knaack M, Martone P, Krueger J, Baldinger SR, Lillemoe TJ, Susnik B, Grimm E, Olet S, Rueth N, Swenson KK. Tsai ML, et al. Among authors: swenson kk. Clin Breast Cancer. 2021 Feb;21(1):47-56. doi: 10.1016/j.clbc.2020.07.003. Epub 2020 Jul 9. Clin Breast Cancer. 2021. PMID: 32739136

Cite

Share

4

Cite

Share

HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.

Lillemoe TJ, Rendi M, Tsai ML, Knaack M, Yarosh R, Grimm E, Susnik B, Krueger J, Olet S, Swenson KK. Lillemoe TJ, et al. Among authors: swenson kk. Int J Breast Cancer. 2021 May 24;2021:6684629. doi: 10.1155/2021/6684629. eCollection 2021. Int J Breast Cancer. 2021. PMID: 34123431 Free PMC article.

Cite

Share

5

Cite

Share

The feasibility of a purpose-renewal intervention after treatment for early stage breast cancer: A brief report.

Radomski MV, Swenson KK, Anheluk M, Zola J, Kreiger R, Rabusch S, Halsten J, Kath K, Carroll G, Zust BL. Radomski MV, et al. Among authors: swenson kk. J Psychosoc Oncol. 2020 Jul-Aug;38(4):501-509. doi: 10.1080/07347332.2019.1692990. Epub 2019 Nov 27. J Psychosoc Oncol. 2020. PMID: 31775574

Cite

Share

6

Cite

Share

Clinicopathologic analysis of a large series of microinvasive breast cancers.

Lillemoe TJ, Tsai ML, Swenson KK, Susnik B, Krueger J, Harris K, Rueth N, Grimm E, Leach JW. Lillemoe TJ, et al. Among authors: swenson kk. Breast J. 2018 Jul;24(4):574-579. doi: 10.1111/tbj.13001. Epub 2018 Feb 24. Breast J. 2018. PMID: 29476574

Cite

Share

7

Cite

Share

Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer.

Swenson KK, Henly SJ, Shapiro AC, Schroeder LM. Swenson KK, et al. Clin J Oncol Nurs. 2005 Apr;9(2):177-84. doi: 10.1188/05.CJON.177-184. Clin J Oncol Nurs. 2005. PMID: 15853161 Review.

Cite

Share

8

Cite

Share

Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw.

Thumbigere-Math V, Michalowicz BS, de Jong EP, Griffin TJ, Basi DL, Hughes PJ, Tsai ML, Swenson KK, Rockwell L, Gopalakrishnan R. Thumbigere-Math V, et al. Among authors: swenson kk. Oral Dis. 2015 Jan;21(1):46-56. doi: 10.1111/odi.12204. Epub 2013 Nov 29. Oral Dis. 2015. PMID: 24286378 Free PMC article.

Cite

Share

9

Cite

Share

Preliminary Efficacy of an Occupation-Oriented Purpose in Life Intervention After Breast Cancer.

Radomski MV, Anheluk M, Carroll GL, Grabe K, Halsten JW, Kath K, Kreiger RA, Lunos ME, Rabusch S, Swenson KK, Zola J. Radomski MV, et al. Among authors: swenson kk. Can J Occup Ther. 2022 Jun;89(2):115-126. doi: 10.1177/00084174211073264. Epub 2022 Jan 18. Can J Occup Ther. 2022. PMID: 35040344

Cite

Share

10

Cite

Share

Radon testing and mitigation: an intervention in a primary care setting.

Nissen MJ, Leach JW, Nissen JA, Swenson KK, Kehn H. Nissen MJ, et al. Among authors: swenson kk. J Cancer Educ. 2012 Jun;27(3):566-72. doi: 10.1007/s13187-012-0346-z. J Cancer Educ. 2012. PMID: 22467225 Clinical Trial.

Cite

Share